Skip to content

HIV needs many more mutations to acquire resistance to darunavir

Triomune approved for PEPFAR use

UNAIDS AIDS epidemic update 2006: headlines

Weight-based ribavirin dosing achieves high success rates in hepatitis C/HIV co-infected patients

More than one in seven pregnancies in east London still poses transmission risk

Tipranavir falls between two stools in naïve trial

Stavudine, didanosine and AZT pose diabetes risk in D:A:D study

Rheumatoid arthritis can be a side-effect of HIV therapy

Is HIV drug resistance in decline in Europe?